Morepen Laboratories

Morepen Laboratories Interest Coverage

The Interest Coverage Ratio of Morepen Laboratories (MOREPENLAB.NS) as of Oct 23, 2026 is 118.94. In the previous year, Interest Coverage Ratio was 103.77 — a change of 14.63% (higher).

Interest Coverage

118.94

YoY

14.63%

Last updated:

Interest Coverage Ratio of Morepen Laboratories is 2025 118.94 . Interest Coverage Ratio of Morepen Laboratories was 2024 103.77 . It decreases by 14.63% higher compared to the previous year.

The Morepen Laboratories Interest Coverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Coverage
Date
Interest Coverage
Jan 1, 2018
7.24 INR
Jan 1, 2019
21.24 INR
Jan 1, 2020
14.37 INR
Jan 1, 2021
294.10 INR
Jan 1, 2022
12.53 INR
Jan 1, 2023
159.56 INR
Jan 1, 2024
103.77 INR
Jan 1, 2025
118.94 INR
The Morepen Laboratories Interest Coverage history
YEARInterest CoverageYoY
118.94+14.63%
103.77-34.97%
159.56+1,173.23%
12.53-95.74%
294.10+1,946.99%
14.37-32.36%
21.24+193.43%
7.24+97.62%
3.66+71.77%
2.13+66.79%
1.28+291.92%
0.33—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Morepen Laboratories Stock analysis

What does Morepen Laboratories do? Morepen Laboratories Ltd. generates revenue through the manufacturing and marketing of bulk drugs, pharmaceutical formulations, and home health products. The company produces active pharmaceutical ingredients (APIs) such as Apixaban, Edoxaban, Sitagliptin, and Rivaroxaban, which are sold to other pharmaceutical manufacturers. Its finished formulations, including Intebact Capsules, Intelicaps Lax, and Rythmix Kid Syrup, are marketed under its own brand for direct consumer sales. Home health products like the Dr. Morepen 49W Room Air Purifier and Dr. Morepen VP06 Breathe Free Vaporizer are sold directly to consumers through retail channels. The company's subsidiaries, Dr. Morepen Limited, Morepen Devices Limited, and Total Care Limited, support these product lines by handling specific manufacturing and distribution tasks. The primary customers for APIs are pharmaceutical companies seeking bulk ingredients for their own formulations. Finished formulations target healthcare consumers and pharmacies, while home health products are sold to households and medical facilities. The company's product segments are clearly divided: APIs for industrial clients, branded formulations for retail consumers, and home health devices for personal use. This segmentation allows Morepen to serve multiple market segments without overlapping product lines. Morepen's revenue streams are diversified across three main areas: API sales to pharmaceutical manufacturers, direct-to-consumer sales of branded formulations, and retail sales of home health products. The company's subsidiaries play a key role in supporting each segment, with Dr. Morepen Limited handling branded formulations, Morepen Devices Limited managing home health devices, and Total Care Limited likely supporting broader healthcare services. This structure ensures that each product line is efficiently managed and marketed to its respective target audience. Morepen Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Morepen Laboratories stock

Interest Coverage Ratio of Morepen Laboratories is 118.94 in 2025.

Interest Coverage Ratio of Morepen Laboratories changed from 103.77 to 118.94, representing a 14.63% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Interest Coverage Ratio Morepen Laboratories since 2006 – with annual values, charts, and detailed analysis.

The Interest Coverage ratio measures a company's ability to pay interest on its debt. Higher ratios indicate greater financial strength and lower default risk.

Interest Coverage = EBIT / Interest Expense

A 'good' varies by industry and company stage. On Eulerpool, you can compare Interest Coverage Ratio's Morepen Laboratories with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Morepen Laboratories

All Key Metrics — Morepen Laboratories